Plans "need to be open to...

...[outcomes-based drug] agreements that combine the full line of business, the medical and pharmacy benefit. A lot of drugs may cost more but save quite a bit on the medical side….Plans have to take a broader look."

— Sarah Donovan, senior vice president at Avalere Health, tells Health Plan Weekly